Number of employees
820
Annual revenue
$331596832
company develops, manufactures, and markets one of the broadest portfolios of injectable products and innovates revolutionary core technology such as its nab™ technology platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life-threatening diseases.